Recent Headlines
Biopharma Industry Standout Robert Proulx Joins Advisory Board of Global Cancer Technology
Global Cancer Technology is developing innovative treatments for deadly diseases like cancer, with a current focus on glioblastoma and breast cancer. To date, Mr. Robert Proulx has held numerous Board positions, is a recognized thought leader in biopharma, and currently holds dual roles as the founder and CEO of Imagion Biosystems. - May 21, 2022 - Global Cancer Technology
LifeBiotic's Botanical Formula Shows Significant Destruction of Multiple GI Cancer Cells
In a new cell model study, the patented LCS101 formula eliminated up to 90% of cancer cells within 72 hours. - May 19, 2022 - Lifebiotic
The ALS TDI Discovery Biology Suite Dedicated in Honor of Liz Bodine to Speed Drug Development in ALS
The ALS Therapy Development Institute (ALS TDI) and Augie’s Quest to Cure ALS are proud to honor the commitment of Liz Bodine to facilitate more effective ALS drug discovery at ALS TDI, the world’s most comprehensive drug discovery lab dedicated solely to ALS. - May 04, 2022 - ALS Therapy Development Institute
Cyclists Support ALS Research with 3-Day, 270-Mile Ride from Boston to Greenwich in Tri-State Trek
Hundreds of riders to join the ride to end ALS this June and raise funds for cutting-edge ALS research. ALS TDI has received a $100,000 match for all donations made to the Tri-State Trek through the month of May. - May 03, 2022 - ALS Therapy Development Institute
“Fight ALS Film Fest” Aims to Shine a Spotlight on the World of ALS
Films explore universal themes of life-changing diseases through examination of ALS. Films and dialogue aim to improve understanding, uplift those affected, and expand the community. - April 25, 2022 - ALS Therapy Development Institute
American Laboratory Products Company Merges with GeneProof
American Laboratory Products Company, Ltd. (“ALPCO”), a specialty in vitro diagnostics company, today announced a merger with GeneProof a.s. (“GeneProof”), a leading molecular diagnostics company based in Brno, Czech Republic. The combination creates a global market leader... - April 21, 2022 - ALPCO
River Valley Relief Launches Relief by RVR Line of Marijuana Concentrates
Arkansas has always been a state known for finding diamonds; just maybe not the kind that are coming out of Fort Smith recently. River Valley Relief Cultivation (“RVR”) has been hard at work producing live diamonds, among other live resin extracts, that were released to many Arkansas... - April 15, 2022 - River Valley Relief
Dr. Claudia C. Cotca of C3 Think Tank Appointed as Advisor Chair of Advanced Technology Academic Research Center (ATARC) on Digital AI & Data Analytics Warfighter Health
Dr. Claudia C. Cotca of C3 Think Tank appointed as Advisor Chair of Advanced Technology Academic Research Center (ATARC) on Digital AI & Data Analytics Warfighter Health. Together with leadership and military health experts, stakeholders and program officers, Dr. Claudia C Cotca will help support and contribute to the scope and mission of ATARC’s Warfighter Health in incorporating responsibly artificial intelligence in military medicine. - April 13, 2022 - C3 Think Tank
CredentialingOne – New Credentialing Outsourcing Company Powered by HealthWare Systems
The credentialing outsourcing company CredentialingOne combines HealthWare Systems automation technology with the expertise of Credentialing Specialists. - April 10, 2022 - HealthWare Systems
Degree Controls Integrates Airflow Monitors and Calibrated Anemometers
Degree Controls integrates airflow monitors and calibrated anemometers for fume hood certification using automated entry of face velocity measurements. - April 09, 2022 - Degree Controls
New Product for Solar Cells from Solaris Chem (Canada)
Solaris Chem expands its product offering for solar cell applications. - March 19, 2022 - Solaris Chem Inc.
Solaris Chem Products Are Now Available in Germany Through Hözel
Their distribution partner in Germany, Hözel, has included Solaris Chem's products to its range for the biotechnology sector. Hözel has been a well-established company since its foundation in 1993. Thanks to its long-standing market presence, it has a lot of experience and knowledge in... - March 19, 2022 - Solaris Chem Inc.
ALPCO Announced Its Support of the Ukrainian People in a Company-Wide Communication to Its Employees
ALPCO (Salem, NH) announced its support of the Ukrainian people in a company-wide communication to its employees. The message outlined the company's contribution to aid refugees through the American Red Cross and Project Hope in the amount of $5,000 each. Additionally, ALPCO is offering an... - March 16, 2022 - ALPCO
FOXG1 Research Foundation Hosts Napa Valley Charity Golf Tournament to Accelerate Research for Pediatric Neurological Disorder
Scientists believe FOXG1 may hold the key to unlocking brain disorders affecting millions, including autism, Alzheimer’s, brain tumors and more. - February 23, 2022 - FOXG1 Research Foundation
American Society for Clinical Laboratory Science Missouri Presents Medical Laboratory Professionals Week
The American Society for Clinical Laboratory Science – Missouri (ASCLS-MO) is proud to present Medical Laboratory Professionals Week (MLPW). The clinical laboratory professional is a key member of today’s health care team. Laboratory professionals have the skills to unlock important... - February 21, 2022 - American Society for Clinical Laboratory Science Missouri
Degree Controls Adds BACnet® Airflow Sensor with Color Touch Screen to Its Suite of Airflow Monitors
Degree Controls launched Sensor200, the first BACnet® airflow sensor with color touch screen for facility managers to achieve local and remote communication. - February 08, 2022 - Degree Controls
MacroArray Diagnostics GmbH (MADx) Partners with ALPCO to Offer a Fully Automated Sample-to-Answer Multiplex Allergy Test Solution to the North American Market
ALPCO (Salem, NH), a leading US producer of novel immunoassay testing platforms, recently announced an exclusive distribution partnership with MacroArray Diagnostics GmbH (Vienna, Austria). Together, they offer a comprehensive line of testing solutions for allergies (IgE-based) and food intolerances (IgG-based), from test material to proprietary hardware and software to process and analyze samples. - February 01, 2022 - ALPCO
Brianna Marie Foundation - Offering Hope to Unborn Babies and Their Families
Are you aware that you can operate on babies prior to birth and give unborn babies that have been diagnosed with a negative fetal diagnosis a chance to live a normal, healthy lifestyle. Parents Aran and Patrick Hissam started a non-profit called the Brianna Marie Foundation in honor of their daughter that passed away ten years ago from a fetal illness known as fetal hydrops. To date, the organization has raised over $550K and funds research around the world. - January 13, 2022 - Brianna Marie Foundation
Dr. Ira Gordon Early, Jr., MD, Continues to Participate in the Cigna Network
Ira Gordon Early, Jr., MD, MPH has been a part of the Cigna Insurance Network since 2017, and continues to support Cigna customers. - December 01, 2021 - Wellness Family Medicine
Pelvic Floor HIFEM (Emsella) Improves the Intensity and Duration of Male Orgasm
Dr. Judson Brandeis studied the Emsella, a device that has been FDA-approved for the treatment of urinary incontinence by stimulating the pelvic floor muscles, in mid-life men with weak or delayed ejaculation. He discovered that four weekly thirty-minute treatments with the Emsella protocol 2 was enough to improve the self-reported intensity and duration of ejaculation. - November 30, 2021 - BrandeisMD
CANNA/Hemp Extraction Labs USA Announces Joint Venture Partnerships for Cannabis Cultivators/Growers and Cannapreneurs
CANNA/Hemp Extraction Labs USA (CHELUSA) announced today they are offering to finance and commission Cannabis Extraction Labs and Cannabis Cloning Labs in NM, NJ, AZ, IL, MT and VA. CHELUSA is looking to form strategic partnerships with Cultivators/Growers and Cannapreneurs in these key states. The... - November 18, 2021 - Hemp Extraction Labs USA
Michael J. Drabkin, MD Joins New York Imaging Specialists
NY Imaging Specialists is proud to announce the addition of Chief of Interventional Radiology (IR), Interventional Oncology for New York Cancer & Blood Specialists (NYCBS), and Executive Director of New York Interventional Radiology Specialists Michael J. Drabkin, MD. He is board-certified in... - November 09, 2021 - New York Imaging Specialists
Cord for Life®, Inc. Announces Cord Blood Clinical Trial Phase I Trial for the Treatment of Lower Back Pain of the Sacroiliac Joint
Cord for Life®, a full-service cord blood bank with over 25 years of experience, today announced plans to conduct a clinical trial to treat lower back pain arising from the Sacroiliac Joint (SIJ) using a biological therapeutic derived from umbilical cord blood. The company has received FDA... - October 29, 2021 - Cord For Life
Pascal Biosciences Announces Financing
Pascal Biosciences Inc. (“Pascal” or the “Company”) (TSXV: PAS) (OTC: PSCBF) (FSE: 6PB-FF) is pleased to announce a non-brokered private placement financing of up to 9,000,000 units (each a “Unit”) of securities at a price of $0.10 per Unit for aggregate gross proceeds of up to $900,000.00 (the “Offering”). - October 29, 2021 - Pascal Biosciences
New Ground-Breaking Treatment for Fibromyalgia Now Available at Harley Street London
TMS has been used for over 20 years to treat a variety of mental health issues. It works by either stimulating or inhibiting specific regions of the brain, helping to return the activity levels of these areas back to normal. At TMS London, they use this technology to target the overactive pain-processing region of people with fibromyalgia, and reduce this activity back to healthy levels, enabling them to help their patients to feel less pain and have an improved quality of life. - October 21, 2021 - Dr. Stephanie Barrett, Consultant Physician and Rheumatologist
Radformation and Aplicaciones Tecnológicas de la Física Launch Automation Partnership at Institut Català d'Oncologia
Radformation, together with their distributor in Spain, Aplicaciones Tecnológicas de la Física, is pleased to announce a partnership with Institut Català d'Oncologia. Institut Català d'Oncologia (ICO) will utilize Radformation’s suite of automation software to... - October 21, 2021 - Radformation
OmeCare and Hillsborough City School District Renew Partnership for Student and Faculty COVID-19 PCR Testing
Partnership helps district ensure safety standards and meet COVID-19 testing protocols for the 2021-2022 school year. - October 16, 2021 - OmeCare
Impact Landscape Survey 2021 Illuminates Global Research Impact Trends
International impact experts, Vertigo Ventures (VV), today announced the release of the Impact Landscape Survey 2021. The report delves into global perspectives on impact, primarily drawn from academics in Australia and the UK, covering areas such as prioritisation of research impact, progress... - October 15, 2021 - Vertigo Ventures
Mary Crowley Cancer Research Welcomes New Chief Executive Officer, Jon Friedenberg
Jon Friedenberg brings a wealth of experience in healthcare leadership to his new appointment as Chief Executive Officer at Mary Crowley Cancer Research. - October 07, 2021 - Mary Crowley Cancer Research
NY Imaging Specialists Brings the Future of Medical Imaging to Nassau County
NY Imaging Specialists today announced the opening of a brand-new comprehensive imaging center in Nassau County. The center includes advanced imaging technology, a women’s health center, an interventional radiology suite, and an adjoining New York Cancer & Blood Specialists medical... - October 04, 2021 - New York Imaging Specialists
OmeCare and LifeSite Announce COVID-19 Testing Solution Partnership
The partnership provides a turnkey approach for workplaces, schools, major conventions and other group events looking to ensure safety and meet governmental mandates for students, staff, employees and event participants. - October 01, 2021 - OmeCare
“Essentials of Diagnosis, Treatment and Application of Cardiac and Peripheral Vascular Diseases” is About to be Released on Amazon, Barnes & Noble Nook and Apple Books
The physical version of the medical research book, “Essentials of Diagnosis, Treatment, and Application of Cardiac and Peripheral Vascular Diseases (Theories, Cases and Analysis)” was published by American Harmony Medical Academic Publisher (AHMAP) on July 26, 2021. - October 01, 2021 - American Harmony Medical Academic Publisher
Launch of TrackImpact.org to Accelerate Global Collaboration Towards a Sustainable Future
International impact experts, Vertigo Ventures (VV), yesterday announced the release of TrackImpact.org, the global research collaboration platform, at the 2021 Impact Symposium. TrackImpact™ is a free-to-access solution that accelerates positive social, economic and environmental impact by... - September 30, 2021 - Vertigo Ventures
Pathologist Creates First Open Source Direct Vision Microscope with an AR Interface - Which You Can Build with a 3D Printer
A UK Pathologist has combined his knowledge of microscopy and 3D printing to develop the world's first direct vision DIY printable advanced microscopy system with features not even seen on the most expensive commercial research microscopes - and has made it all Open Source. The PUMA microscope system is poised to be a game changer in the democratization of microscopy and is totally portable for use in remote field work. See the "PUMA Microscope" YouTube channel for more. - September 27, 2021 - PUMA
Cayman Chemical Receives Grant to Evaluate Use of KMN-159 to Accelerate Dental Implant Osseointegration
The National Institute of Dental and Craniofacial Research has awarded Cayman Chemical with a $1,700,500 grant to explore Cayman’s patented small molecule bone repair agent KMN-159 as the active pharmaceutical ingredient (API) in a drug-device combination to improve the mechanical anchorage... - September 19, 2021 - Cayman Chemical Company
Scientists at AbboMax, Inc. Developed the New Panels of Monoclonal Antibodies to Study B- and T-Cell Lymphomas
Lymphoma is a malignant transformation of either B or T cells or their subtypes. All lymphoma subtypes combined are the seventh most common cancer in the United States. The B-cell lymphomas are types of lymphoma affecting B cells. About 85% of lymphomas are of B-cell origin. T-cell lymphomas are lymphomas that affect T cells. AbboMax has developed the new panels of monoclonal antibodies to study B- and T-cell lymphomas. - September 03, 2021 - AbboMax, Inc.
Defined Bioscience Licenses FGF2-STAB (G3) for Use in Stem Cell Media
Defined recently concluded a licensing agreement with Czech Republic-based Enantis for global use of Enantis’ patented FGF2-STAB® technology both alone and in stem cell media formulations. FGF2-STAB®, originally coined FGF2-G3, was developed by Enantis and Masaryk University, using... - August 30, 2021 - Defined Bioscience Inc.
Reverie Psychedelics and Indiana Health Group Partner to Develop World-Class Psychedelic Research Center
Reverie Psychedelics (Reverie), a leading and rapidly growing psychedelic – assisted psychotherapy clinic and research organization, has further expanded its footprint and capabilities by partnering with Indiana Health Group (IHG), the largest provider of psychiatric and mental health and... - August 05, 2021 - Reverie Psychedelics
The Cause of Nearsightedness is Explained for the First Time; Work at MIT and Multivision Research Leads to Dr. Medina's Conclusion That Lenses Are the Cause of Myopia
The cause of myopia (nearsightedness) has been unveiled in the article: “The cause of myopia development and progression: Theory, evidence, and treatment” available online as an article-in-press in the scientific journal Survey of Ophthalmology on July 28, 2021. - August 01, 2021 - Antonio Medina
Defined Bioscience Launches with $1.5M SBIR from the NIH to Advance Stem Cell Media
Defined recently received a $1.5M in Phase II SBIR award from the National Institutes of Health to develop defined media over the next two years. - July 03, 2021 - Defined Bioscience Inc.
Pepex Biomedical Receives Approval on a Series of Critical New Patents
Worldwide approval grants the Company exclusivity on a number of methods and manufacturing processes associated with its novel electrochemical biosensors. - July 01, 2021 - Pepex Biomedical, Inc.
Paras Biopharmaceuticals Finland Oy Named as One of the Top Pharma Outsourcing Companies in Europe 2021
Paras Biopharmaceuticals Highlights Company Innovations that Decode and Create Biologics Medicines for Unmet Medical Needs (Pharma Tech Outlook, USA) - June 22, 2021 - Paras Biopharmaceuticals Finland Oy
Targeted Pharmaceuticals and George Mason University Announce First-Ever Preclinical Study Using Cannabinoids in an Organoid Model
Study Examines the Effects of Cannabinoids Treating Central Nervous System (CNS) Viruses including HIV Associated Dementia - June 16, 2021 - Targeted Pharmaceuticals
Rivkin Center Hires Molly O’Connor as Incoming Executive Director
The Rivkin Center, a Seattle-based nonprofit working to improve women’s health by helping them prevent, detect early and survive ovarian and breast cancer, has hired Molly O’Connor to lead the organization upon the retirement of the current executive director. - June 09, 2021 - Rivkin Center
MedSend and On-Belay Partner to Train African Orthopedic Surgeons
On-Belay Medical and MedSend jointly announce their partnership in training national orthopedic surgeons in Africa. On-Belay Medical has committed $125,000 towards MedSend’s five-year residency programs for training national orthopedic surgeons. On-Belay is an innovative medical device... - June 04, 2021 - MedSend
ALS TDI Launches New Young Faces of ALS Program
The ALS Therapy Development Institute's Young Faces of ALS program spreads awareness about the impact that ALS can have on young people; launch coincides with MLB's inaugural Lou Gehrig Day. - June 02, 2021 - ALS Therapy Development Institute
Solaris Chem Expands Its Distributors Network
Solaris Chem is a company working in the field of fine organic chemistry, synthesizing materials for the organic electronic industry since 2007. His R&D program is mainly focused on the synthesis of custom made semi-conducting polymers, fullerene derivatives and dyes specially formulated for... - May 26, 2021 - Solaris Chem Inc.
Updated Findings of COVID-19 Impact on Biopharmaceutical Industry & CRO Outsourcing Report
2021 Survey Quantifies Current and Expected impact of COVID-19 on Clinical Development and CRO Outsourcing and Changes Since 2020 - May 25, 2021 - Life Science Strategy Group, LLC
Valley Radiology Acquires Philips Ingenuity 128-slice CT/PET
San Diego North County Healthcare Providers and Patients Benefit from Enhanced Imaging Technology provided by Valley Radiology's Acquisition of 128-slice Philips Ingenuity CT/PET. - May 17, 2021 - Valley Radiology
Advanced Silicon Group Closes Seed Preferred Equity Offering and Adds Alan Watson and Sarah Kelly to Board
Advanced Silicon Group, Inc. (ASG), a pioneer in silicon nanotechnology focused on developing novel biosensors, announced today the closing of a $1,020,000 seed preferred stock offering led by Cherrystone Angel Group with participation by MIT Alumni Angels of Northern California, Sidecar Angels and other private investors and the addition of two new Directors, Alan Watson, PhD, MBA and Sarah Kelly, PhD to its Board of Directors. - May 16, 2021 - Advanced Silicon Group